October 17, 2024 – Talk Bio

Bavarian Nordic’s Mpox Vaccine Demonstrates Equivalent Efficacy in Teens and Adults: NIH Study

6 months ago talkbio0Tagged Adolescent (age group), Adult, Antibodies, Bavarian Nordic, Effectiveness, mpox vaccine, MVA, MVA-BN vaccine, NIH, NIH Mouse, Response process, Safety

Mpox vaccine, Bavarian Nordic, MVA-BN vaccine, Teenagers, Adults, Antibody response, Safety, Efficacy, NIH study

Sanofi Invests €300M in Orano Med for Next-Generation Radioligand Therapies

6 months ago talkbio0Tagged 212Pb, AlphaMedix, Infrequent, Malignant Neoplasms, Multiple Epiphyseal Dysplasia, radioligand therapies, sanofi, targeted alpha, targeted alpha therapies

Sanofi, Orano Med, Radioligand Therapies, Rare Cancers, AlphaMedix, Lead-212 (212Pb), Targeted Alpha Therapies

FDA Approves Novocure’s Optune Lua for Metastatic Non-Small Cell Lung Cancer Treatment

6 months ago talkbio0Tagged Approved, fields, Metastatic non-small cell lung cancer, Neoplasms, Non-Small Cell Lung Carcinoma, Novocure, Optune Lua, United States Food and Drug Administration

Optune Lua, FDA approval, metastatic non-small cell lung cancer, Tumor Treating Fields, Novocure, NSCLC treatment.

Eisai to Seek Reconsideration of TGA’s Initial Decision on Lecanemab for Alzheimer’s Disease in Australia

6 months ago talkbio0Tagged Alzheimer 's disease, Australia, Biogen, Eisai, Lecanemab, TGA

Lecanemab, Alzheimer’s disease, Therapeutic Goods Administration (TGA), Eisai, Biogen, reconsideration, Australia

Eli Lilly Expands Global Innovation Reach with New Research Centers in China

6 months ago talkbio0Tagged Biotechnology, China, Drug Development, Eli, Eli Lilly, Gateway, innovation, Research Organization

Eli Lilly, China, Research Centers, Innovation, Gateway Labs, Biotechnology, Drug Development

Enhancing GI Tolerability of GLP-1 Receptor Agonists: A Path to Improved Therapeutic Outcomes

6 months ago talkbio0Tagged Administration occupational activities, agonists, Diabetes, gastrointestinal tolerability, GLP-1 receptor, Obesity, therapeutic strategies

GLP-1 receptor agonists, gastrointestinal tolerability, therapeutic strategies, diabetes management, obesity treatment

FDA Places Clinical Hold on Novavax’s COVID-19-Influenza Combination and Standalone Influenza Vaccine Trials

6 months ago talkbio0Tagged COVID19 (disease), Novavax, Peripheral motor neuropathy, Study on Hold, trials, United States Food and Drug Administration, Vaccines

Novavax, FDA, Clinical Hold, COVID-19, Influenza, Vaccine Trials, Motor Neuropathy

KdT Ventures Secures $100M Fourth Fund to Fuel Early-Stage Biotech Startups

6 months ago talkbio0Tagged Early-stage, frontier, Investments, KdT, Science, startups, Ventures

KdT Ventures, $100M fund, early-stage startups, biotech, frontier science, life sciences investment

Wave Life Sciences Sees Historic Stock Surge Following Breakthrough in RNA Editing Therapy

6 months ago talkbio0Tagged Clinical Trials, Hereditary Diseases, liver complications, Lung, RNA Editing, surge, Wave Life Sciences, WVE-006

Wave Life Sciences, RNA editing, genetic condition, lung and liver complications, WVE-006, biotech, stock surge, clinical trial data

Predictive Analytics and AI: Reducing Emergency Room Visits through Enhanced Triage and Resource Allocation

6 months ago talkbio0Tagged Accident and Emergency department, Artificial Intelligence, Health care facility, Machine Learning, Optimization, Predictive analytics, Resource Allocation, Triage

Predictive analytics, Artificial intelligence (AI), Emergency department (ED) visits, Triage, Resource allocation, Machine learning (ML), Healthcare optimization